🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2a, randomized, double blind, parallel group, multicenter s...
Status
Completed
Location
University of Alabama at Birmingham, Dermatology at the Whitaker Clinic
Start Date
2016-12-15
Trial ID
NCT02974868
Treatments Being Tested
The objectives of this study are to evaluate the efficacy, safety, tolerabi...
Status
Completed
Location
Dothan Surgery Center
Start Date
2018-02-02
Trial ID
NCT03395184
Treatments Being Tested
The purpose of this study is to characterize the effect of kidney impairmen...
Status
Completed
Location
Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy
Start Date
2020-07-03
Trial ID
NCT04260464
Treatments Being Tested
An open-label, fixed sequence, 2-period including a single oral dose 60 mg ...
Status
Completed
Location
PRA Health Sciences
Start Date
2018-12-10
Trial ID
NCT03770039
Assessment of PF-06700841 in participants with moderate to severe active, g...
Status
Completed
Location
UAB Department of Medicine Clinical Research Enterprise
Start Date
2019-04-18
Trial ID
NCT03845517
Treatments Being Tested
The purpose of this study is to determine whether PF-06700841 is safe and e...
Status
Completed
Location
Northwest Arkansas Clinical Trials Center, PLLC/Hull Dermatology, PA
Start Date
2016-12
Trial ID
NCT02969018
Treatments Being Tested
This Phase 1 study will assess the pharmacokinetic effect of multiple doses...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2020-08-24
Trial ID
NCT04267250
Treatments Being Tested
This is a 52 week Phase 2b study designed to evaluate the efficacy at 16 we...
Status
Completed
Location
Rheumatology Research Unit
Start Date
2019-06-13
Trial ID
NCT03963401
Treatments Being Tested
An open-label, fixed-sequence, 2-period study to investigate the effect of ...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2019-09-24
Trial ID
NCT04090047
Treatments Being Tested